Want to see CARL full AI Analyst Report?
Carlsmed, Inc. (CARL) Stock Statistics & Valuation Metrics
Total Valuation
Carlsmed, Inc. has a market cap or net worth of $408.18M. The enterprise value is $214.83M.
- Market Cap
- $408.18M
- Enterprise Value
- $214.83M
Share Statistics
Carlsmed, Inc. has 27,302,744 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 27,302,744
- Owned by Insiders
- 33.52%
- Owned by Institutions
- 9.23%
Financial Efficiency
Carlsmed, Inc.’s return on equity (ROE) is -0.30 and return on invested capital (ROIC) is -26.22%.
- Return on Equity (ROE)
- -0.30
- Return on Assets (ROA)
- -0.23
- Return on Invested Capital (ROIC)
- -26.22%
- Return on Capital Employed (ROCE)
- -0.26
- Revenue Per Employee
- 397.72K
- Profits Per Employee
- -233.34K
- Employee Count
- 127
- Asset Turnover
- 0.39
- Inventory Turnover
- 6.76
Valuation Ratios
The current PE Ratio of Carlsmed, Inc. is -11.04. Carlsmed, Inc.’s PEG ratio is -0.12.
- PE Ratio
- -11.04
- PS Ratio
- 6.48
- PB Ratio
- 4.85
- Price to FCF
- -11.99
- Price to Operating Cash Flow
- -11.96
- PEG Ratio
- -0.12
Income Statement
In the last 12 months, Carlsmed, Inc. had revenue of 50.51M and earned -29.63M in profits. Earnings per share was -2.12.
- Revenue
- 50.51M
- Gross Profit
- 38.04M
- Operating Income
- -30.57M
- Pretax Income
- -29.63M
- Net Income
- -29.63M
- EBITDA
- -27.92M
- Earnings Per Share (EPS)
- -2.12
Cash Flow
In the last 12 months, operating cash flow was -34.15M and capital expenditures -58,000, giving a free cash flow of -34.20M billion.
- Operating Cash Flow
- -34.15M
- Free Cash Flow
- -34.20M
- Free Cash Flow per Share
- -1.26
Dividends & Yields
Carlsmed, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -8.77%
- Earnings Yield
- -9.35%
Stock Price Statistics
- Beta
- 2.07
- 52-Week Price Change
- 16.52%
- 50-Day Moving Average
- 15.02
- 200-Day Moving Average
- 12.38
- Relative Strength Index (RSI)
- 53.32
- Average Volume (3m)
- 109.88K
Important Dates
Carlsmed, Inc. upcoming earnings date is Nov 10, 2026, After Close (Not Confirmed).
- Last Earnings Date
- Aug 05, 2026
- Next Earnings Date
- Nov 10, 2026
- Ex-Dividend Date
- ―
Financial Position
Carlsmed, Inc. as a current ratio of 8.87, with Debt / Equity ratio of 17.61%
- Current Ratio
- 8.87
- Quick Ratio
- 8.74
- Debt to Market Cap
- 0.09
- Net Debt to EBITDA
- 2.45
- Interest Coverage Ratio
- -21.38
Taxes
In the past 12 months, Carlsmed, Inc. has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Carlsmed, Inc. EV to EBITDA ratio is -15.18, with an EV/FCF ratio of -10.70.
- EV to Sales
- 5.78
- EV to EBITDA
- -15.18
- EV to Free Cash Flow
- -10.70
- EV to Operating Cash Flow
- -10.71
Balance Sheet
Carlsmed, Inc. has $89.22M in cash and marketable securities with $21.92M in debt, giving a net cash position of $67.31M billion.
- Cash & Marketable Securities
- $89.22M
- Total Debt
- $21.92M
- Net Cash
- $67.31M
- Net Cash Per Share
- $2.47
- Tangible Book Value Per Share
- $3.10
Margins
Gross margin is 76.63%, with operating margin of -61.09%, and net profit margin of -57.42%.
- Gross Margin
- 76.63%
- Operating Margin
- -61.09%
- Pretax Margin
- -40.82%
- Net Profit Margin
- -57.42%
- EBITDA Margin
- -38.06%
- EBIT Margin
- -38.71%
Analyst Forecast
The average price target for Carlsmed, Inc. is $19.67, which is 11.43% higher than the current price. The consensus rating is Strong Buy
- Price Target
- $19.67
- Price Target Upside
- 30.94% Upside
- Analyst Consensus
- Strong Buy
- Analyst Count
- 5
- Revenue Growth Forecast
- 65.39%
- EPS Growth Forecast
- -39.10%
Scores
- Smart Score
- 6
- AI Score
- 47
